John Partridge


John Partridge is a Chambers-ranked litigation partner in Gibson, Dunn & Crutcher’s Denver office and a Co-Chair of the firm’s FDA and Health Care Practice Group. His practice focuses on government and internal investigations, white collar defense, and complex litigation for clients in the life sciences and health care industries. Mr. Partridge, whom LMG has ranked as a rising star in life sciences, has particular experience with the False Claims Act, the Foreign Corrupt Practices Act, and the Federal Food, Drug, and Cosmetic Act, including defending major corporations in investigations pursued by the U.S. Department of Justice (DOJ) and the U.S. Securities and Exchange Commission (SEC). Mr. Partridge has represented clients in criminal and civil enforcement actions relating to alleged health care fraud and abuse, including actions conducted by DOJ, the U.S. Food and Drug Administration’s Office of Criminal Investigations, the Department of Health and Human Services Office of Inspector General, and State Attorneys General.  His substantive experience includes cases involving allegations relating to, among other things, clinical trials, off-label promotion, sampling practices, importation of regulated products, and anti-kickback issues.  Among other publications, Mr. Partridge and his colleagues wrote the criminal enforcement and pharmaceutical sampling chapters of PLI’s Pharmaceutical Compliance and Enforcement Answer Book.